Form D — ELIXIRGEN THERAPEUTICS, INC.
0001744333-25-000002 · filed Apr 9, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $3,600,000
- Reported amount sold
- $3,600,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ELIXIRGEN THERAPEUTICS, INC.
- CIK
- 1744333
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 855 N. WOLFE ST.
BALTIMORE, Maryland 21205 - Phone
- 443-451-5300
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
AKIHIRO KO · Executive OfficerBALTIMORE, Maryland Find on LinkedIn ↗
-
HIROAKI KOBAYASHI · DirectorBALTIMORE, Maryland Find on LinkedIn ↗
-
MINORU KO · DirectorBALTIMORE, Maryland Find on LinkedIn ↗
-
THOMAS WHITE · DirectorBALTIMORE, Maryland Find on LinkedIn ↗
-
SHAUNA CALLAHAN · DirectorBALTIMORE, Maryland Find on LinkedIn ↗
-
JEFFREY CLELAND · DirectorBALTIMORE, Maryland Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗